Twin Tree Management
MDGL icon

Twin Tree Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Twin Tree Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-336
Closed -$102K – 1688
2025
Q2 		$102K Sell
336
-4,992
-94% -$1.49M ﹤0.01% 1526
2025
Q1 		$1.76M Sell
5,328
-4,410
-45% -$1.45M ﹤0.01% 1169
2024
Q4 		$3M Buy
+9,738
New +$2.74M 0.01% 1065
2024
Q2 		– Sell
-30,297
Closed -$7.21M – 1542
2024
Q1 		$8.09M Buy
+30,297
New +$7.14M 0.02% 700
2023
Q3 		– Sell
-1,385
Closed -$320K – 1402
2023
Q2 		$320K Sell
1,385
-1,897
-58% -$514K ﹤0.01% 1086
2023
Q1 		$795K Buy
+3,282
New +$894K ﹤0.01% 1034
2019
Q2 		– Sell
-62
Closed -$8K – 1442
2019
Q1 		$8K Buy
+62
New +$7.71K ﹤0.01% 1193

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Twin Tree Management's MDGL Position: Q3 2025 in Review

Twin Tree Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2025, closing a stake of 336 shares — an estimated $102K sold.

Twin Tree Management first reported a position in MDGL in Q1 2019 and held it in 7 quarters. The position peaked at $8.09M in Q1 2024. 352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • Twin Tree Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Twin Tree Management sold 336 Madrigal Pharmaceuticals shares in Q3 2025, an estimated $102K.
  • Twin Tree Management first reported a position in Madrigal Pharmaceuticals in Q1 2019 and held it in 7 quarters.
  • Twin Tree Management's Madrigal Pharmaceuticals position peaked at $8.09M in Q1 2024.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on Twin Tree Management's 13F filing for Q3 2025, filed 13 Nov 2025.